Safety trial of oral coadministration of 5-aminolevulinic acid phosphate with sodium ferrous citrate to healthy subjects
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Bladder cancer; Glioma; Solid tumours
- Focus Adverse reactions
- 22 Jun 2017 Status changed from active, no longer recruiting to completed.
- 19 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 07 Jul 2016 New trial record